Data anonymization challenges in brain signals

Introduction

Data anonymization in brain signals refers to the process of removing or modifying identifying information from neurological data so that individuals cannot easily be identified. Brain signals are collected through technologies such as electroencephalography (EEG), functional magnetic resonance imaging (fMRI), brain-computer interfaces (BCIs) and neural implants.

These technologies are increasingly used in neuroscience research, medical diagnosis, rehabilitation, artificial intelligence and biotechnology. Brain signals may reveal information about cognitive activity, emotional responses, neurological conditions and behavioural patterns.

However, anonymising brain data is particularly difficult because neural signals may contain unique patterns associated with an individual. Even after removing names and other direct identifiers, researchers may be able to reconnect the information with a particular person using additional datasets. This creates important legal challenges concerning privacy, consent, data protection and responsible scientific research.

Legal framework governing brain signal anonymization

1. Information Technology Act, 2000

The Information Technology Act, 2000 provides India's principal legal framework for electronic information and cybersecurity.

Relevant provisions include:

Section 43: Provides compensation for unauthorised access, copying or damage to computer systems and data.

Section 66: Addresses computer-related acts committed dishonestly or fraudulently.

Section 72: Addresses breach of confidentiality and privacy in specified circumstances.

Section 70B: Establishes CERT-In and its cybersecurity incident-response responsibilities.

These provisions may become relevant when neurological databases are unlawfully accessed or confidential brain signal information is disclosed.

2. Digital Personal Data Protection Act, 2023

The DPDP Act is relevant when brain signal datasets contain digital personal data relating to identifiable individuals.

Removing direct identifiers does not automatically make information anonymous if an individual remains identifiable through reasonably available information or other means. The legal treatment of genuinely anonymised information differs from that of identifiable personal data.

The Act establishes requirements concerning lawful processing, security safeguards and personal data breaches, subject to applicable commencement provisions and rules.

3. European Union General Data Protection Regulation (GDPR)

The GDPR provides an important international framework for protecting neurological information.

Article 4: Defines personal data and pseudonymisation.

Article 9: Provides additional protection for special categories of personal data, including health-related information.

Article 25: Requires data protection by design and by default.

Article 32: Establishes requirements for appropriate security measures.

Brain signal information that reveals or permits inferences about an individual's health may receive special-category protection under the GDPR.

4. Constitutional privacy protection in India

Article 21 of the Indian Constitution protects the fundamental right to privacy. This protection is particularly important for brain signals because neurological information may reveal highly personal aspects of an individual's physical and cognitive condition.

Major data anonymization challenges in brain signals

1. Unique neurological patterns

Brain signals may contain individual characteristics that distinguish one person from another. Even when names and identification numbers are removed, these patterns may create re-identification risks.

2. Re-identification through combined datasets

Researchers may combine anonymised brain signals with other available information, such as medical records, demographic information or previously collected neurological data. This may make it possible to identify individuals.

3. Sensitive mental information

Brain signal analysis may reveal information concerning neurological disorders, attention patterns, sleep activity and other health-related characteristics. Unauthorised disclosure can create privacy and discrimination concerns.

4. Continuous data collection

Brain-computer interfaces and wearable neurological devices may collect signals repeatedly over extended periods. Continuous collection increases the amount of information available for identification and profiling.

5. Artificial intelligence risks

Machine learning systems may identify hidden patterns in anonymised neurological datasets. These systems may sometimes infer information that was not part of the original research objective.

6. Data sharing and international transfers

Neuroscience research frequently involves universities, hospitals, technology companies and international research institutions. Different privacy laws may create difficulties in maintaining consistent anonymisation standards.

Legal and technical safeguards

Organisations collecting brain signals should adopt strong privacy and data governance procedures.

Data minimisation: Collect only neurological information necessary for the research purpose.

Pseudonymisation: Replace direct identifiers with coded identifiers and store the identification key separately.

Anonymisation testing: Evaluate whether individuals can be re-identified using available datasets.

Encryption: Protect neurological information during storage and transmission.

Access restrictions: Limit access to authorised researchers and healthcare professionals.

Informed consent: Explain the purposes of collection, processing, sharing and potential secondary use.

Retention controls: Establish appropriate retention and deletion procedures.

Independent audits: Periodically assess privacy risks and the effectiveness of anonymisation techniques.

Importantly, pseudonymisation is not equivalent to anonymisation. If information can still be linked to an individual using an additional key, it generally remains personal data under applicable data protection frameworks.

Important case laws

1. Justice K.S. Puttaswamy v. Union of India (2017)

The Supreme Court of India recognised privacy as a fundamental right under Article 21 of the Constitution. The judgment established that informational privacy is an essential component of personal liberty. It is particularly relevant to brain signal datasets because neurological information may reveal highly private details about an individual's health and cognitive functioning.

2. S. and Marper v. United Kingdom (2008)

The European Court of Human Rights examined the retention of DNA samples and fingerprints of individuals who had not been convicted. It held that blanket and indefinite retention violated Article 8 of the European Convention on Human Rights. The judgment provides an important analogy for protecting sensitive biological and neurological information against unnecessary retention.

3. Breyer v. Germany (2016)

The Court of Justice of the European Union considered whether dynamic IP addresses could constitute personal data where additional information held by another party could enable identification. The judgment is relevant to brain signal anonymisation because it demonstrates that information may remain personal data even when direct identification is not immediately possible.

4. Google Spain SL v. AEPD (2014)

The Court of Justice of the European Union examined the processing of personal information by search engines and recognised circumstances in which individuals could request removal of certain search results. The judgment supports broader principles concerning personal data control and responsible information processing.

5. Carpenter v. United States (2018)

The United States Supreme Court examined government access to historical cell-site location information and recognised the substantial privacy implications of detailed digital records. Although the case concerned location data rather than brain signals, it is relevant by analogy because continuously collected neurological information may reveal extensive details about an individual's private life.

These judgments do not directly establish legal standards for brain signal anonymisation. They provide analogous principles concerning privacy, identification, sensitive data retention and digital information protection.

Regulatory challenges and emerging issues

Brain signal anonymisation creates new regulatory questions because neurological information may reveal characteristics that individuals have not consciously disclosed.

One major concern is whether anonymised brain data can be reused for commercial purposes without additional consent. Another issue involves the responsibility of technology companies that develop AI systems capable of analysing neurological information.

International research collaborations also require clear agreements concerning data access, retention, transfer and re-identification restrictions.

Regulators and research institutions must therefore develop privacy safeguards that consider both the technical characteristics of neural data and the fundamental rights of research participants.

Conclusion

Data anonymisation challenges in brain signals represent an important emerging issue in biotechnology, neuroscience and information privacy law. The Information Technology Act, 2000, applicable provisions of the DPDP Act, 2023 and international frameworks such as the GDPR provide important legal foundations. Judicial decisions such as Puttaswamy, Breyer and S. and Marper establish relevant principles concerning informational privacy and identification risks. Effective anonymisation requires data minimisation, pseudonymisation, re-identification testing, informed consent and continuous privacy assessments to protect individuals while supporting responsible neurological research.c